News Articles for Australian Pharmaceutical Industries

Wesfarmers' health and beauty division has upped its offer to $180 million to acquire SILK Laser Clinics after previously walking away from negotiations.

Wesfarmers is one step closer to completing its acquisition of Australian Pharmaceutical Industries after securing shareholder approval.

Australia's competition regulator has given the all clear for Wesfarmers to acquire Australian Pharmaceutical Industries, a key condition needed to close the deal.

Woolworths Group has withdrawn its bid for Australian Pharmaceutical Industries (API), leaving Wesfarmers as the only suitor for the Priceline Pharmacy owner.

Wesfarmers says it won't accept any takeover offer made by Woolworths for API, as the retail giants fight for ownership of Australian Pharmaceutical Industries.

Woolworths has pitched an $872 million takeover offer for Australian Pharmaceutical Industries, pitting the retail giant against Wesfarmers.

Wesfarmers will make a foray into the health and beauty sector after winning the takeover battle with Sigma Healthcare for Priceline owner Australian Pharmaceutical Industries.

Sigma Healthcare has withdrawn efforts to merge with Priceline owner Australian Pharmaceutical Industries leaving Wesfarmers to push ahead with a takeover.

Wesfarmers has bolstered its chances of taking over Australian Pharmaceutical Industries after buying a 19.3 per cent stake.

Wesfarmers looks like it may have sealed a takeover of Australian Pharmaceutical Industries (API) after an increased offer for all shares.

Priceline Pharmacy owner Australian Pharmaceutical Industries has rejected a takeover offer from Wesfarmers.

Wesfarmers wants to buy Australian Pharmaceutical Industries, announcing today a $687 million offer for the business.